Shuzhen Lyu

机构：Capital Medical University, Beijing Shijitan Hospital · ORCID：0000-0002-2341-966X

发表论文 12 篇 · 总被引 175 次 · h-index 5

代表论文

• Current and future burden of breast cancer in Asia: A GLOBOCAN data analysis for 2022 and 2050 (2024 · The Breast · 被引 70)
• Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor‐Infiltrating Lymphocytes: A Cohort Study (2020 · Journal of Immunology Research · 被引 57)
• Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer (2022 · Breast Cancer Targets and Therapy · 被引 12)
• Consistent expression of PD-L1 in tumor microenvironment with peripheral PD-1/PD-L1 in circulating T lymphocytes of operable breast cancer: a diagnostic test (2022 · Diagnostic Pathology · 被引 11)
• Assessing the African burden of breast cancer: A demographic analysis using Global Cancer Observatory 2022 (2025 · European Journal of Surgical Oncology · 被引 9)
• CD155-TIGIT/CD96/CD226 immune checkpoint axis interacting with tumor-infiltrating lymphocytes to exhibit diverse prognostic effects on breast cancer: a cohort study (2025 · Frontiers in Immunology · 被引 5)